EMMA (Emmaus Life Sciences) Inventories, Raw Materials & Components: $1.22 Mil (As of Mar. 2026)


What is Emmaus Life Sciences Inventories, Raw Materials & Components?

Emmaus Life Sciences EMMA -16.67% Inventories, Raw Materials & Components is $1.22 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Emmaus Life Sciences's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $1.22 Mil.

Emmaus Life Sciences's quarterly raw materials increased from Sep. 2025 ($1.22 Mil) to Dec. 2025 ($1.26 Mil) but then declined from Dec. 2025 ($1.26 Mil) to Mar. 2026 ($1.22 Mil).

Emmaus Life Sciences's annual raw materials declined from Dec. 2023 ($1.33 Mil) to Dec. 2024 ($1.15 Mil) but then increased from Dec. 2024 ($1.15 Mil) to Dec. 2025 ($1.26 Mil).

Emmaus Life Sciences Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Emmaus Life Sciences's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmaus Life Sciences Inventories, Raw Materials & Components Chart

Emmaus Life Sciences Annual Data
Trend Sep16 Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.44 1.39 1.33 1.15 1.26

Emmaus Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.15 1.15 1.22 1.26 1.22

Emmaus Life Sciences Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $1.22 Mil mean?
Emmaus Life Sciences (EMMA) has a Inventories, Raw Materials & Components of $1.22 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Emmaus Life Sciences and its competitors.
Is Emmaus Life Sciences' Inventories, Raw Materials & Components too high?
Emmaus Life Sciences' current Inventories, Raw Materials & Components is $1.22 Mil.
How does Emmaus Life Sciences' Inventories, Raw Materials & Components compare to CERO and AGTX?
Emmaus Life Sciences' Inventories, Raw Materials & Components of $1.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Emmaus Life Sciences and its competitors. Emmaus Life Sciences's current Inventories, Raw Materials & Components is $1.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emmaus Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Emmaus Life Sciences (EMMA) is currently considered Fairly Valued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading right at its estimated fair value. The current Inventories, Raw Materials & Components is $1.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Emmaus Life Sciences (EMMA), the current Inventories, Raw Materials & Components is $1.22 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emmaus Life Sciences Business Description

Address 21250 Hawthorne Boulevard, Suite 800, Torrance, CA, USA, 90503
Emmaus Life Sciences Inc is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sales of the Company's product Endari (prescription grade L-glutamine oral powder), to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. Endari is reimbursable by the Centers for Medicare and Medicaid Services, and every state provides coverage for Endari for outpatient prescriptions to all eligible Medicaid enrollees within their state Medicaid programs. Endari is also reimbursable by many commercial payors.